Haleon plc
HLNCF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$45.16B
Close$
$9.63
127.6% upside
Current Fair Value
127.6% upsideUndervalued by 127.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $45.16 Billion |
|---|---|
| Enterprise Value | $52.54 Billion |
| Annual dividend | $0.10 |
| Dividend yield | 1.92% |
| Earnings per Share | $0.19 |
| Beta | 0.24 |
| Outstanding Shares | 9,056,179,775 |
Return
| Return on Equity | 11.32% |
|---|---|
| Return on Assets | 5.69% |
| Return on Invested Capital | 11.06% |
Valuation & Multiples
| P/E Ratio | 21.01 |
|---|---|
| PEG | 21.01 |
| Price to Sales | 4.23 |
| Price to Book Ratio | 4.23 |
| Enterprise Value to Revenue | 3.83 |
| Enterprise Value to EBIT | 18.14 |
| Enterprise Value to Net Income | 28 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 0.5 |
Revenue Sources
No data
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$0.13
Consensus analyst estimateRevenue Estimate
$7.41 B
Consensus analyst estimateNext Earnings Call
Expected Date
March 4, 2027
EPS Estimate
$0.05
Consensus analyst estimateRevenue Estimate
$7.62 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Haleon plc
24,561 employees
CEO: Brian James McNamara
Haleon plc operates as a global consumer healthcare enterprise, actively involved in the research, development, production, and distribution of a diverse range of products. Its business activities cover extensive regions, including North...